- $1.88bn
- $2.85bn
- $1.32bn
- 95
- 46
- 99
- 94
2019 February 28th | 2020 February 29th | 2021 February 28th | R2022 February 28th | 2023 February 28th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 927 | 1,062 | 839 | 1,324 | 1,324 |
Cost of Revenue | |||||
Gross Profit | 199 | 237 | 189 | 296 | 296 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 850 | 982 | 777 | 1,150 | 1,150 |
Operating Profit | 77 | 79.3 | 61.6 | 174 | 174 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 63 | 64.9 | 51 | 88.7 | 88.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 50.1 | 48.2 | 39.6 | 66.3 | 66.3 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 51.2 | 48.2 | 39.6 | -53 | -53 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 51.2 | 48.2 | 39.6 | -61.2 | -61.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.92 | 2.36 | 2.12 | 2.74 | 2.74 |
Dividends per Share |